GPT and liver disorder: Chinese guidelines (2022 versions) suggest deciding whether antiviral therapy needs to be initiated based on a comprehensively disease progression by assessing serum HBV DNA, ALT level, and liver disease severity, combined with factors such as age, family history, and concomitant diseases [32].